Company
NeuroPace
NeuroPace makes the RNS System, a brain-responsive neurostimulation implant for drug-resistant focal epilepsy.
- Based
- Mountain View, California
- Website
- www.neuropace.com
NeuroPace is a commercial-stage medical device company incorporated in Delaware in 1997 and based in Mountain View, California. Its RNS System is a closed-loop, implantable brain-computer interface that continuously monitors brain activity through leads placed at the seizure focus and delivers responsive electrical stimulation to interrupt abnormal activity before a person experiences seizures, indicated for adults with drug-resistant focal epilepsy. The company went public on Nasdaq in 2021 under the ticker NPCE.
People